Zenith Dissection Endovascular System (ZDEG/ZDES)
William Cook Europe Aps · Decision date Aug 4, 2026
What did the FDA decide?
FDA records P180001/S018 as a supplement to PMA P180001, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 4, 2026.
FDA approval order statement
changes to the supplier of packaging materials
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 4, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P180001/S018
- Regulatory pathway
- PMA supplement
- Applicant
- William Cook Europe Aps
- Product code
- MIH
- Decision code
- OK30
- Decision date
- Aug 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.
- Applicant
- William Cook Europe Aps
- Product code
- MIH
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P180001/S016 · Related supplement
Zenith Dissection Endovascular System
P180001/S017 · Related supplement
Zenith Fenestrated AAA Endovascular Graft
P180001/S018 received
Application receipt date recorded by FDA.
P180001/S018 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P180001. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P180001
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Zenith Dissection Endovascular SystemP180001/S016 | William Cook Europe Aps | PMA supplement | May 8, 2026 | FDA |
Zenith Fenestrated AAA Endovascular GraftP180001/S017 | William Cook Europe Aps | PMA supplement | May 21, 2026 | FDA |
Explore the linked device profile
Other records with product code MIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
RelayPro Thoracic Stent-Graft Delivery SystemP200045/S025 | Bolton Medical, Inc. | PMA supplement | Oct 28, 2026 | FDA |
| Cook, Inc. | PMA supplement | Sep 17, 2026 | FDA | |
| Cook, Inc. | PMA supplement | Aug 4, 2026 | FDA | |
| Cook Medical Incorporated | PMA supplement | Aug 4, 2026 | FDA | |
GORE EXCLUDER Conformable AAA EndoprosthesisP200030/S026 | W. L. Gore and Associates, Inc. | PMA supplement | Jul 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
William Cook Europe Aps
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Sandet 6, Dk-4632, Bjaeverskov
Sources and methodology
- Original FDA record: P180001/S018
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





